17 January 2017
News and Views
Links and Services
The most recent issue of the Inflammatory Bowel Diseases investigates antibodies to infliximab and risk of infusion reactions in patients with IBD.
Antibodies to infliximab have been associated with a risk of infusion reactions in some studies o
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors